These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27385180)

  • 1. Role of Transporters in Drug Development.
    Arya V; Kiser JJ
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S7-S10. PubMed ID: 27385180
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of Hepatic Drug Transporters in Drug Development.
    Liu H; Sahi J
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S11-22. PubMed ID: 27385168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic drug transporters: the journey so far.
    Riley RJ; Foley SA; Barton P; Soars MG; Williamson B
    Expert Opin Drug Metab Toxicol; 2016; 12(2):201-16. PubMed ID: 26670591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transporter-mediated tissue targeting of therapeutic molecules in drug discovery.
    Zhou J; Xu J; Huang Z; Wang M
    Bioorg Med Chem Lett; 2015 Mar; 25(5):993-7. PubMed ID: 25650254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.
    Brian W; Tremaine LM; Arefayene M; de Kanter R; Evers R; Guo Y; Kalabus J; Lin W; Loi CM; Xiao G
    Pharmacogenomics; 2016 Apr; 17(6):615-31. PubMed ID: 27045656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro methods to support transporter evaluation in drug discovery and development.
    Brouwer KL; Keppler D; Hoffmaster KA; Bow DA; Cheng Y; Lai Y; Palm JE; Stieger B; Evers R;
    Clin Pharmacol Ther; 2013 Jul; 94(1):95-112. PubMed ID: 23588315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporter pharmacogenetics: do we need function? Do we need motion?
    Pastor-Anglada M
    Pharmacogenomics; 2013 Oct; 14(13):1537-40. PubMed ID: 24088123
    [No Abstract]   [Full Text] [Related]  

  • 8. Imaging transporters: Transforming diagnostic and therapeutic development.
    Mann A; Han H; Eyal S
    Clin Pharmacol Ther; 2016 Nov; 100(5):479-488. PubMed ID: 27327047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transporter assays as useful in vitro tools in drug discovery and development.
    Volpe DA
    Expert Opin Drug Discov; 2016; 11(1):91-103. PubMed ID: 26512742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transporters in drug development: advancing on the Critical Path.
    Huang SM; Woodcock J
    Nat Rev Drug Discov; 2010 Mar; 9(3):175-6. PubMed ID: 20222180
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetics of drug transporters in the enterohepatic circulation.
    Stieger B; Meier PJ
    Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics and systems biology of membrane transporters.
    Yan Q
    Mol Biotechnol; 2005 Jan; 29(1):75-88. PubMed ID: 15668521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of endogenous roles of transporters for drug discovery: hitchhiking and metabolite-likeness.
    Kell DB
    Nat Rev Drug Discov; 2016 Feb; 15(2):143. PubMed ID: 26837595
    [No Abstract]   [Full Text] [Related]  

  • 14. The utility of modeling and simulation in drug development and regulatory review.
    Huang SM; Abernethy DR; Wang Y; Zhao P; Zineh I
    J Pharm Sci; 2013 Sep; 102(9):2912-23. PubMed ID: 23712632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane transporters in drug development.
    ; Giacomini KM; Huang SM; Tweedie DJ; Benet LZ; Brouwer KL; Chu X; Dahlin A; Evers R; Fischer V; Hillgren KM; Hoffmaster KA; Ishikawa T; Keppler D; Kim RB; Lee CA; Niemi M; Polli JW; Sugiyama Y; Swaan PW; Ware JA; Wright SH; Yee SW; Zamek-Gliszczynski MJ; Zhang L
    Nat Rev Drug Discov; 2010 Mar; 9(3):215-36. PubMed ID: 20190787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transporter studies in drug development: experience to date and follow-up on decision trees from the International Transporter Consortium.
    Tweedie D; Polli JW; Berglund EG; Huang SM; Zhang L; Poirier A; Chu X; Feng B;
    Clin Pharmacol Ther; 2013 Jul; 94(1):113-25. PubMed ID: 23588318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane transporters and drug development: relevance to pharmacogenomics, nutrigenomics, epigenetics, and systems biology.
    Yan Q
    Methods Mol Biol; 2010; 637():1-21. PubMed ID: 20419427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
    Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
    Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel, 384-well high-throughput assay panels for human drug transporters: drug interaction and safety assessment in support of discovery research.
    Tang H; Shen DR; Han YH; Kong Y; Balimane P; Marino A; Gao M; Wu S; Xie D; Soars MG; O'Connell JC; Rodrigues AD; Zhang L; Cvijic ME
    J Biomol Screen; 2013 Oct; 18(9):1072-83. PubMed ID: 24062352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
    Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
    Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.